Just Released: "Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013"
Global Markets Direct's, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD). Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, Half Year is built using...
View full press release